Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-09-29

FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Original Application (Granules Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Granules Pharmaceuticals' generic fixed-dose combination tablet of losartan potassium and hydrochlorothiazide for the treatment of hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan potassium and hydrochlorothiazide (losartan potassium and hydrochlorothiazide)

Snippet

ORIG AP for LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE)